| Serial Number | 85691679 |
| Word Mark | UMOOZE |
| Filing Date | Tuesday, July 31, 2012 |
| Status | 710 - CANCELLED - SECTION 8 |
| Status Date | Friday, March 8, 2024 |
| Registration Number | 4393791 |
| Registration Date | Tuesday, August 27, 2013 |
| Mark Drawing | 5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
| Published for Opposition Date | Tuesday, January 8, 2013 |
| Description of Mark | The mark consists of the stylized letters "UMOOZE" with the two "O" 's overlapping. |
| Goods and Services | Adjuvants for medical purposes; Antiallergic medicines; Anti-cancer preparations; Medicinal herbal extracts for medical purposes; Pharmaceutical and medicinal preparations and substances for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, ocular disorders, or bone diseases, for use in dermatology, oncology, hematology and ophthalmology and for gastroenterological disorders or liver ailments; Pharmaceutical and medicinal preparations for the treatment of brain diseases or disorders and autoimmune diseases or disorders; Dietary and nutritional supplements for medical use; Dietary supplements for treating fatigue or liver support; Animal feed additive for use as a nutritional supplement for medical purposes; Dietary supplements for human consumption or for animals; Nutritional additives for medical purposes for use in foods for human consumption or for animals; Animal feed supplements; Dietary pet supplements in the form of pet treats; Fungi preparations for medical or veterinary use for treating disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, ocular disorders, brain diseases or disorders, autoimmune diseases or disorders, or bone diseases, for use in dermatology, oncology, hematology and ophthalmology and for gastroenterological disorders or liver ailments. Pharmaceutical preparations and substances for veterinary purposes for treating disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, ocular disorders, brain diseases or disorders, autoimmune diseases or disorders, or bone diseases, for use in dermatology, oncology, hematology and ophthalmology and for gastroenterological disorders or liver ailments; Chemical preparations for medicinal purposes for treating disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, ocular disorders, brain diseases or disorders, autoimmune diseases or disorders, or bone diseases, for use in dermatology, oncology, hematology and ophthalmology and for gastroenterological disorders or liver ailments; Cardiovascular pharmaceuticals; Cardiovascular treatment preparations; Pharmaceuticals preparations for the treatment of kidney diseases |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 2 - Sec. 8 - Entire Registration |
| Class Status Date | Friday, March 8, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | Tuesday, July 31, 2012 |
| First Use In Commerce Date | Tuesday, January 8, 2013 |
| Party Name | GOLDEN BIOTECHNOLOGY CORPORATION |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | New Taipei City TW |
| Party Name | GOLDEN BIOTECHNOLOGY CORPORATION |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | New Taipei City TW |
| Party Name | GOLDEN BIOTECHNOLOGY CORPORATION |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | New Taipei City TW |
| Event Date | Event Description |
| Friday, March 8, 2024 | CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9 |
| Saturday, August 27, 2022 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED |
| Sunday, March 10, 2019 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED |
| Sunday, March 10, 2019 | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. |
| Saturday, March 9, 2019 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| Wednesday, January 30, 2019 | TEAS SECTION 8 & 15 RECEIVED |
| Monday, August 27, 2018 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| Tuesday, August 27, 2013 | REGISTERED-PRINCIPAL REGISTER |
| Saturday, July 20, 2013 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| Friday, July 19, 2013 | LAW OFFICE REGISTRATION REVIEW COMPLETED |
| Friday, July 19, 2013 | ASSIGNED TO LIE |
| Monday, July 1, 2013 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Wednesday, June 19, 2013 | STATEMENT OF USE PROCESSING COMPLETE |
| Tuesday, May 21, 2013 | USE AMENDMENT FILED |
| Wednesday, June 19, 2013 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Tuesday, May 21, 2013 | TEAS STATEMENT OF USE RECEIVED |
| Tuesday, March 5, 2013 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, January 8, 2013 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, January 8, 2013 | PUBLISHED FOR OPPOSITION |
| Wednesday, December 19, 2012 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, November 28, 2012 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, November 28, 2012 | ASSIGNED TO EXAMINER |
| Thursday, August 9, 2012 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, August 3, 2012 | NEW APPLICATION ENTERED |